$GNMK FDA approval today!! HOD $9.48 , now trading at $5.28 GenMark Diagnostics, Inc. (NASDAQ:GNMK) announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the company's ePlex SARS-CoV-2 Test. GenMark's ePlex molecular diagnostics platform is already achieving commercial success. The company recently reported that sales for ePlex in the fourth quarter jumped 59% year over year to $60.3 million, generating more than two-thirds of total revenue in the quarter. GenMark's next quarterly update will almost certainly be even better. $AHPI $AYTU fool.com/investing/2020/03/...
View original message